CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS · Delayed Price · Currency is USD
0.0341
0.00 (0.00%)
At close: Mar 9, 2026

CERO Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
11269236223
Market Cap Growth
-83.57%-83.24%-70.89%6.05%-
Enterprise Value
91470236-
Last Close Price
0.03120.0022000.0020540.6019820.00
PB Ratio
-0.22-6.081574.06-21.45-29.01
Debt / Equity Ratio
-0.20-0.8367.45-0.06-
Net Debt / Equity Ratio
0.220.8932.60-0.020.14
Net Debt / EBITDA Ratio
0.060.11-0.20--
Quick Ratio
0.230.440.430.0211.20
Current Ratio
0.300.500.561.3813.88
Return on Assets (ROA)
-210.22%-178.66%-20.20%-1.63%-
Return on Capital Employed (ROCE)
385.10%1355.00%-474.00%-25.00%-0.30%
Earnings Yield
-4819.98%-72.13%-10.61%-0.28%-0.24%
Source: S&P Capital IQ. Standard template. Financial Sources.